Sarah Karr - ABIOMED Communications Mang
Insider
Sarah Karr is Communications Mang of ABIOMED
| Phone | 978 777-8411 |
| Web | www.abiomed.com |
ABIOMED Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1824 %, meaning that it created $0.1824 on every $100 dollars invested by stockholders. ABIOMED's management efficiency ratios could be used to measure how well ABIOMED manages its routine affairs as well as how well it operates its assets and liabilities.ABIOMED currently holds 10 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. ABIOMED has a current ratio of 7.38, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ABIOMED's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Jeremy Trahan | Viemed Healthcare | 54 | |
| Philip Brooks | Sonida Senior Living | 61 | |
| RoseMarie Ohlsson | Alvotech | N/A | |
| Milton Seligman | Ambev SA ADR | 69 | |
| Joe Padilla | Willamette Valley Vineyards | N/A | |
| Max Levy | Sonida Senior Living | 33 | |
| David Johnson | Sonida Senior Living | N/A | |
| Jeffrey Cellucci | Sonida Senior Living | 32 | |
| Eduardo Horai | Ambev SA ADR | 38 | |
| Noah Beren | Sonida Senior Living | N/A | |
| David Fintzen | JetBlue Airways Corp | N/A | |
| Elizabeth Windram | JetBlue Airways Corp | N/A | |
| Ryan Hellard | SNDL Inc | 35 | |
| Jeremy Falke | Sonida Senior Living | 49 | |
| Ming Li | Alvotech | 47 | |
| Joseph McClellan | Alvotech | 50 | |
| Fernando Tennenbaum | Ambev SA ADR | 44 | |
| John Ferry | Willamette Valley Vineyards | 58 | |
| Mark Levick | Alvotech | 60 | |
| Andrew Stordeur | SNDL Inc | 44 | |
| Robbie Madan | SNDL Inc | 45 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 |
ABIOMED Leadership Team
Elected by the shareholders, the ABIOMED's board of directors comprises two types of representatives: ABIOMED inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ABIOMED. The board's role is to monitor ABIOMED's management team and ensure that shareholders' interests are well served. ABIOMED's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ABIOMED's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Howley, VP and General Manager of Global Sales | ||
| Michael Minogue, Chairman, CEO and President Member of Special Stock Option Committee and Member of Executive Committee | ||
| Andrew Greenfield, Vice President - Healthcare Solutions | ||
| Thorsten Siess, Ex Officer | ||
| Ingrid Ward, Director Relations | ||
| Matthew Plano, Ex Integration | ||
| Todd Trapp, CFO, Vice President | ||
| Sarah Karr, Communications Mang | ||
| Marc Began, Gen VP | ||
| David Weber, Scientific Advisor |
ABIOMED Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ABIOMED a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 16.32 B | |||
| Shares Outstanding | 45.09 M | |||
| Shares Owned By Insiders | 2.02 % | |||
| Shares Owned By Institutions | 97.00 % | |||
| Number Of Shares Shorted | 753.62 K | |||
| Price To Earning | 76.38 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |